Low molecular weight blood plasma proteome - a source of differential diagnostic biomarkers of ovarian cancer
At present, there is no screening test for the early detecting of ovarian cancer, one of the most lethal form of gynaecological malignancy in the worldwide. In this study the new methodology for the search of tumor markers of ovarian cancer, involving profiling the low-molecular blood plasma proteom...
Saved in:
Main Authors: | V. Ye. Shevchenko (Author), N. Ye. Arnotskaya (Author), N. R. Pogosyan (Author), O. G. Ioseliany (Author), A. N. Gritsay (Author) |
---|---|
Format: | Book |
Published: |
ABV-press,
2014-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery of potential ovarian cancer biomarkers using low molecular weight blood plasma proteome profiling by mass spectrometry
by: V. E. Shevchenko, et al.
Published: (2014) -
Proteomics in the diagnosis of ovarian cancer
by: V. E. Shevchenko, et al.
Published: (2014) -
Identification of proteomic markers for metastasis of ovarian cancer
by: V. E. Shevchenko, et al.
Published: (2014) -
Salivary biomarkers and proteomics: future diagnostic and clinical utilities
by: A. V. Mitronin, et al.
Published: (2021) -
Targeted proteomics of plasma extracellular vesicles uncovers MUC1 as combinatorial biomarker for the early detection of high-grade serous ovarian cancer
by: Tyler T. Cooper, et al.
Published: (2024)